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A bstract: The oxidation of cyanide (CN-) to a m uch less toxic thiocyanate (SCN-) is the m ain in vivo  bio­
chem ical pathway for CN- detoxification. SCN-  is excreted mainly in urine. This study was performed to inves­
tigate the effect o f lipoic acid (LA) on the urinary excretion of thiocyanate (SCN- ; rhodanate) in rats. Groups 
o f the animals were treated intraperitoneally (i.p.) as follows: group 1: potassium cyanide (KCN) (1 mg/kg); 
group 2: KCN (1 mg/kg) + LA (100 mg/kg). Urine was collected for 24 h  and the pooled samples were exam ­
ined for SCN-  levels. The obtained results indicated that the treatment o f animals with potassium cyanide and 
LA in com bination significantly increased the urinary excretion o f SCN-  in comparison w ith the respective val­
ues in the KCN-alone-treated group. It indicates that LA increased the rate o f CN-  detoxification in rats.
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Cyanides (CN- ), salts of hydrogen cyanide 
(HCN), and HCN itself have always been feared as 
poisons because of their toxic properties. Cyanides 
are synthesized, excreted and degraded in nature by 
many species of bacteria, plants and insects. 
Cyanides have also been used for various purposes 
in industry. Toxic level of cyanides in the body is 
generated after administration of certain drugs, like 
laetrile and sodium nitroprusside. Cyanide targets 
primarily mitochondrial cytochrome oxidase, there­
by causing the inhibition of cellular respiration, 
acceleration of anaerobic glycolysis, and consequent 
tissue hypoxia and metabolic lactic acidosis.
The oxidation of CN-  to a much less toxic thio- 
cyanate (the oral LD50 values of cyanide and thio- 
cyanate in rats are 3 and 854 mg/kg, respectively) 
(1) is the main in vivo biochemical pathway for CN-  
detoxification according to the following reaction:
CN-  + S ^  SCN-
The conversion of CN-  to SCN-  is catalyzed by 
sulfurtransferases: rhodanese (EC. 2.8.1.1; TST), 3- 
mercaptopyruvate sulfurtransferase (EC 2.8.1.2; 
MST) and cystathionine y-lyase (EC 4.4.1.1; CSE). 
The role of these enzymes consists in sulfane sulfur 
transfer to CN- .
Sulfane sulfur is a divalent sulfur atom (-S-) 
covalently bound to another sulfur atom (R-S-S- 
H). The elemental sulfur (S8) and outer sulfur 
atom of thiosulfate (S=SO3- ) exhibit also sulfane 
sulfur properties. The sulfane sulfur-containing 
compounds are endogenous m etabolites formed 
from cysteine. Cysteine is synthesized from the 
essential amino acid methionine to a lim ited 
extent and for this reason, it is called a sem i­
essential amino acid. Cysteine and m ethionine are 
only two of the twenty amino acids normally pres­
ent in proteins and belong to the sulfur-containing 
amino acids (SAA). Thiocyanate is excreted 
mainly in urine.
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Lipoic acid (R)-5-(1,2-dithiolan-3-yl)pentanoic
acid, LA, C8H14O2S2), a naturally occurring dithiol
compound, is a cofactor for a number of multienzy-
matic complexes involved in energy metabolism.
Dihydrolipoic acid (6,8-dimercaptooctanoic acid,
DHLA, C8H16O2S2) is the reduced form of LA.
Exogenous LA has been shown to exhibit pharma-
cological activities (2ñ6). Literature data indicate
that the LA/DHLA system participates also in sul-
fane sulfur metabolism. Namely, it was shown that
DHLA serves as a sulfane sulfur acceptor in the
TST- and MST-catalyzed sulfane sulfur transfer. In
these reactions DHLA hydropersulfide is formed,
from which sulfane sulfur is released in the form of
hydrogen sulfide (H2S) and LA is produced con-
comitantly (7, 8).
Thus, it can be assumed that LA may be
involved in cyanide detoxification reactions in the
body. This study was undertaken to investigate for
the first time the effect of LA administration on the
urinary excretion of SCNñ in rats exposed to CNñ. 
EXPERIMENTAL
Animals 
The experiments were carried out on male
Wistar rats (300ñ350 g). Animals were housed in
metabolic cages for urine collection, in a room at a
constant temperature of 20 ± 2OC with a natural
light-dark cycle. They had free access to standard
pellet diet and water. Groups consisted of 6 animals
each. The pharmaceutical with the commercial
name Thiogamma, which contains LA as an active
substance was used in our experiments as a source
of LA. All procedures were approved by the Ethics
Committee for Animal Research in KrakÛw (license
no. 44/2012). 
Groups were treated as follows: Group 1: KCN
(1 mg/kg b.w., i.p.). Group 2: KCN (1 mg/kg b.w.;
i.p.) + LA (100 mg/kg b.w.; i.p.). 
Urine was collected for 24 h after drug injection
and the pooled samples were examined for SCNñ
levels. 
Methods
Determination of thiocyanate level in the urine of
rats 
The content of SCNñ was determined by the
method of Goldstein (9). SCNñ present in the urine
reacts with Fe3+ ions to form the colored compound
Fe(SCN)3, the concentration of which is measured
spectrophotometrically at a wavelength of λ = 450 nm.
SCNñ concentration is calculated based on a standard
curve prepared for potassium thiocyanate (KSCN).
Statistical analysis 
Data are presented as the means ± SEM. The sta-
tistical significance of the differences between the
means was analyzed using Studentís t-test. A level
of p ≤ 0.001 was adopted to indicate statistical sig-
nificance.
RESULTS 
The results presented in Table 1 indicated that
24-h urinary excretion of SCNñ was significantly
higher in rats which were administered KCN and
LA in combination in comparison with the group
treated with KCN alone (4.86 µmol/24 ± 0.23 h vs.
2.5 µmol/24 ± 0.37 h, respectively).
DISCUSSION AND CONCLUSIONS
The obtained results showed that LA increased
CNñ detoxification rate in rats, which indicates that
this compound can act as a CNñ antidote. It was
confirmed also by studies of other authors. M¸ller
and Krieglstein reported that one hour of preincuba-
tion with 1 µM DHLA reduced damage of neurons
from chick embryo telencephalon caused by 1 mM
sodium cyanide (10). Abdel-Zaher et al. demonstrat-
ed that intraperitoneal injection of KCN into mice
produced clonic and tonic seizures. The severity of
convulsions was dose-dependent. The ED50 value of
KCN was 4.8 mg/kg. In contrast, animals adminis-
tered LA at a dose of 100 mg/kg before KCN injec-
tion showed the increase in CNñ ED50 values from
4.8 mg/kg to 9.4 mg/kg (10). The same authors also
demonstrated that LA (25, 50 and 100 mg/kg) given
to mice 15 min before KCN injection increased the
CNñ LD50 values (based on 24 h mortality) from 6
mg/kg to 6.2, 7.2 and 11.2 mg/kg, respectively (11).
It has also been reported that LA protects choliner-
gic cells against sodium nitroprusside neurotoxicity
(12). 
Therefore, it is a plausible proposal that LA
plays a role in cyanide detoxification process.
However, further studies are necessary to explain
the mechanisms of these processes. Swenne et al.
exposed normal and protein-malnourished rats to the
cyanogenic compound acetonitrile (CH3CN); that
study indicated that urinary excretion of SCNñ was
lower in rats fed a low-protein diet compared to rats
fed a normal-protein diet (13). Analysis of the above
data suggests that there may be some analogy with
the present results. Namely, when rats are exposed
to CNñ the urinary SCNñ excretion is higher in ani-
mals, which were fed a normal protein diet and in
those which were administered LA. It indicates that
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LA acted in that case like a normal-protein diet. The
literature data indicate that a low-protein diet
increases CNñ toxicity, because the concentrations
of sulfane sulfur compounds are dependent on the
availability of SAA from dietary protein (14). Tor-
Agbidye et al. proposed that SAA deficiency might
be a risk factor for human neurological diseases
among protein-poor populations subsisting on cas-
sava (Manihot esculenta), a cyanophoric plant (15). 
In 1981, Westley found that purified bovine liver
TST had a high turnover rate of almost 20,000/min
in vitro, which meant that 1 mole of TST could con-
vert 20,000 moles of CNñ to SCNñ per 1 minute.
This high turnover rate means that the availability of
sulfane sulfur compounds, rather than the TST
activity, is the rate limiting factor for CNñ conver-
sion to SCNñ (16). 
Therefore, it appears that all the data warrant
hypothesis that LA increases CNñ to SCNñ trans-
formation rate by elevation of the level of sulfane
sulfur compounds in the body. It was confirmed also
by data from Bilska et al. studies, which demon-
strated for the first time in vivo that the level of sul-
fane sulfur compounds in the heart, liver and kidney
of rats given LA at a dose of 100 mg/kg/24 h for 8
days was significantly higher than in the control LA-
free group (17). The same experiments indicated
that LA elevated also TST activity in several tissues
of rats (17). However, in the light of the present
knowledge, LA sulfur is not a sulfane sulfur, and
TST does not participate in its formation. However,
on the other hand, Frankenberg indicated that the
administration of TST together with sulfane sulfur
compounds had a good antidotic effect against CNñ
poisoning in mice, yet, when sulfane sulfur com-
pounds were given without TST, the antidotic effect
was weaker (18).
So, based on literature data, it can be hypothe-
sized that, apart from TST, LA also elevates activi-
ty of MST and/or CSE (Fig. 1). It is known that CSE
and MST belong to enzymes which are directly
involved in the generation of sulfane sulfur com-
pounds. MST is also known to be implicated in the
CNñ to SCNñ conversion reaction. As for CSE, in
vivo studies indicated that the inhibition of this
enzyme by L-propargylglycine increased the toxici-
ty of CNñ (19). It can indicate that, like for MST, the
CSE-catalyzed reactions lead both to the production
of sulfane sulfur compounds, and to CNñ to SCNñ
Figure 1. A proposal of the mechanism of LA action in processes leading to the formation of sulfane sulfur compounds: thiosulfate, thio-
cysteine and thiocystine, and in the CNñ to SCNñ transformation. TST ñ thiosulfate: cyanide sulfurtransferase (EC 2.8.1.1; rhodanese).
MST ñ 3-mercaptopyruvate:cyanide sulfurtransferase (EC 2.8.1.2). CSE ñ cystathionine γ-lyase (EC 4.4.1.1; cystathionase) 
Table 1. The urinary excretion of SCNñ in rats treated with KCN
in the absence or presence of LA.
Treatment SCN- [µmol/24 h] 
KCN 2.50 ± 0.37  
KCN + LA 4.86a ± 0.23  
aStudentís t-test, significance p < 0.001 in comparison with KCN
group
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conversion. Already in the 1960s, it was document-
ed that the products of CSE-catalyzed cleavage of
cystine (Cys-S-S-Cys) produced sulfane sulfur
donors for TST (20, 21). 
In summary, this paper clearly demonstrated that
the treatment of rats with KCN and LA in combina-
tion significantly increased the urinary excretion of
SCNñ in comparison with the respective values in
the KCN-alone-treated group, which confirms the
hypothesis suggesting that LA plays a role in the
CNñ detoxification process. These results suggest
that biological activity of LA may be connected with
sulfane sulfur metabolism (Fig. 1). It points to
potential new pharmacological properties of LA.
However, confirmation of this hypothesis requires
further studies.
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